Manulife (Manufacturers Life Insurance)
RCEL icon

Manulife (Manufacturers Life Insurance)’s Avita Medical RCEL Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,020
Closed -$58.3K – 2981
2025
Q2 		$58.3K Buy
+11,020
New +$80.2K ﹤0.01% 2866
2024
Q4 		– Sell
-10,428
Closed -$112K – 3013
2024
Q3 		$112K Sell
10,428
-410
-4% -$3.85K ﹤0.01% 2838
2024
Q2 		$85.8K Buy
+10,838
New +$103K ﹤0.01% 2863
2022
Q2 		– Sell
-10,694
Closed -$90.7K – 3113
2022
Q1 		$90.7K Sell
10,694
-3,085
-22% -$28.4K ﹤0.01% 2971
2021
Q4 		$165 Buy
13,779
+245
+2% +$3.74K ﹤0.01% 2963
2021
Q3 		$240K Sell
13,534
-509
-4% -$9.61K ﹤0.01% 2847
2021
Q2 		$288K Buy
+14,043
New +$277K ﹤0.01% 2844

Other funds holding RCEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s RCEL Position: Q3 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Avita Medical (RCEL) in Q3 2025, closing a stake of 11,020 shares — an estimated $58.3K sold.

Manulife (Manufacturers Life Insurance) first reported a position in RCEL in Q2 2021 and held it in 7 quarters. The position peaked at $288K in Q2 2021. 76 funds tracked by Wall St. Rank hold RCEL as of Q3 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining Avita Medical position as of Q3 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 11,020 Avita Medical shares in Q3 2025, an estimated $58.3K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Avita Medical in Q2 2021 and held it in 7 quarters.
  • Manulife (Manufacturers Life Insurance)'s Avita Medical position peaked at $288K in Q2 2021.
  • 76 funds tracked by Wall St. Rank held Avita Medical as of Q3 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2025, filed 14 Nov 2025.